Who is sponsoring NCT00236223?

NCT00236223 is sponsored by Glostrup University Hospital, Copenhagen.

What condition does NCT00236223 study?

NCT00236223 studies Pain, Postoperative.

What drugs are being tested in NCT00236223?

Interventions: Gabapentin + dexamethasone + ketamine, Placebo.

What is the status of NCT00236223?

NCT00236223 is currently TERMINATED.

Last reviewed 2008-05-14 · How we verify

The Effect of Gabapentin, Low Dose Ketamine, Paracetamol, NSAID and Dexamethasone on Pain and Opioid Requirements in Patients Scheduled for Primary Total Hip Replacement

NCT00236223 Phase 4 TERMINATED

Patients scheduled for primary hip replacement needs postoperative pain treatment, i.e. morphine. Morphine has side-effects: nausea, vomiting, sedation and dizziness. These side-effects are unpleasant for the patients and sometimes keeps them at bed longer time than needed. We investigate in new combinations of analgesics for postoperative pain, hoping to minimize the need for morphine.

Details

Lead sponsor	Glostrup University Hospital, Copenhagen
Phase	Phase 4
Status	TERMINATED
Enrolment	48
Start date	2005-10
Completion	2008-05

Conditions

Pain, Postoperative

Interventions

Gabapentin + dexamethasone + ketamine
Placebo

Primary outcomes

The total amount of morphine needed postoperatively from 0-4h; and 0-24h, administered by a patient controlled pain treatment.(PCA) — 0-24h

Countries

Denmark